TY - JOUR
T1 - Breathing variability during propofol/remifentanil procedural sedation with a single additional dose of midazolam or s-ketamine
T2 - a prospective observational study
AU - van den Bosch, O F C
AU - Alvarez-Jimenez, R
AU - Schet, S G
AU - Delfsma, K
AU - Loer, S A
N1 - Publisher Copyright:
© 2021, The Author(s).
PY - 2022/8
Y1 - 2022/8
N2 - PURPOSE: Regulation of spontaneous breathing is highly complex and may be influenced by drugs administered during the perioperative period. Because of their different pharmacological properties we hypothesized that midazolam and s-ketamine exert different effects on the variability of minute ventilation (MV), tidal volume (TV) and respiratory rate (RR).METHODS: Patients undergoing procedural sedation (PSA) with propofol and remifentanil received a single dose of midazolam (1-3 mg, n = 10) or s-ketamine (10-25 mg, n = 10). We used non-invasive impedance-based respiratory volume monitoring to record RR as well as changes in TV and MV. Variability of these three parameters was calculated as coefficients of variation.RESULTS: TV and MV decreased during PSA to a comparable extent in both groups, whereas there was no significant change in RR. In line with our hypothesis we observed marked differences in breathing variability. The variability of MV (- 47.5% ± 24.8%, p = 0.011), TV (- 42.1% ± 30.2%, p = 0.003), and RR (- 28.5% ± 29.3%, p = 0.011) was significantly reduced in patients receiving midazolam. In contrast, variability remained unchanged in patients receiving s-ketamine (MV + 16% ± 45.2%, p = 0.182; TV +12% ± 47.7%, p = 0.390; RR +39% ± 65.2%, p = 0.129). After termination of PSA breathing variables returned to baseline values.CONCLUSIONS: While midazolam reduces respiratory variability in spontaneously breathing patients undergoing procedural sedation, s-ketamine preserves variability suggesting different effects on the regulation of spontaneous breathing.
AB - PURPOSE: Regulation of spontaneous breathing is highly complex and may be influenced by drugs administered during the perioperative period. Because of their different pharmacological properties we hypothesized that midazolam and s-ketamine exert different effects on the variability of minute ventilation (MV), tidal volume (TV) and respiratory rate (RR).METHODS: Patients undergoing procedural sedation (PSA) with propofol and remifentanil received a single dose of midazolam (1-3 mg, n = 10) or s-ketamine (10-25 mg, n = 10). We used non-invasive impedance-based respiratory volume monitoring to record RR as well as changes in TV and MV. Variability of these three parameters was calculated as coefficients of variation.RESULTS: TV and MV decreased during PSA to a comparable extent in both groups, whereas there was no significant change in RR. In line with our hypothesis we observed marked differences in breathing variability. The variability of MV (- 47.5% ± 24.8%, p = 0.011), TV (- 42.1% ± 30.2%, p = 0.003), and RR (- 28.5% ± 29.3%, p = 0.011) was significantly reduced in patients receiving midazolam. In contrast, variability remained unchanged in patients receiving s-ketamine (MV + 16% ± 45.2%, p = 0.182; TV +12% ± 47.7%, p = 0.390; RR +39% ± 65.2%, p = 0.129). After termination of PSA breathing variables returned to baseline values.CONCLUSIONS: While midazolam reduces respiratory variability in spontaneously breathing patients undergoing procedural sedation, s-ketamine preserves variability suggesting different effects on the regulation of spontaneous breathing.
KW - Breathing variability
KW - Midazolam
KW - Procedural sedation
KW - Respiratory volume monitoring
KW - s-Ketamine
UR - https://www.scopus.com/pages/publications/85118953347
U2 - 10.1007/s10877-021-00773-2
DO - 10.1007/s10877-021-00773-2
M3 - Article
C2 - 34767130
SN - 1387-1307
VL - 36
SP - 1219
EP - 1225
JO - Journal of Clinical Monitoring and Computing
JF - Journal of Clinical Monitoring and Computing
IS - 4
ER -